Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study. (Q50422379)
Jump to navigation
Jump to search
scientific article published on 22 February 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study. |
scientific article published on 22 February 2018 |
Statements
1 reference
Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study. (English)
1 reference
1 reference
Andreas Hochhaus
1 reference
Bruno Martino
1 reference
Norbert Gattermann
1 reference
Andrzej Hellmann
1 reference
Giuseppe Saglio
1 reference
Jesper Stentoft
1 reference
Eibhlin Conneally
1 reference
Valentin Garcia-Gutierrez
1 reference
Philipp D le Coutre
1 reference
Susanne Saussele
1 reference
Francis J Giles
1 reference
Jerald P Radich
1 reference
Weiping Deng
1 reference
Nancy Krunic
1 reference
Véronique Bédoucha
1 reference
Prashanth Gopalakrishna
1 reference
22 February 2018
1 reference
144
1 reference
945-954
1 reference
5
1 reference
22 February 2018
1 reference
Identifiers
1 reference
1 reference